EP 1082419 A2 20010314 - COMBINATION THERAPY USING NUCLEIC ACIDS AND CONVENTIONAL DRUGS
Title (en)
COMBINATION THERAPY USING NUCLEIC ACIDS AND CONVENTIONAL DRUGS
Title (de)
KOMBINATIONSTHERAPIE MIT NUCLEINSÄUREN UND KONVENTIONELLEN WIRKSTOFFE
Title (fr)
TRAITEMENT ASSOCIE UTILISANT DES ACIDES NUCLEIQUES ET DES MEDICAMENTS CLASSIQUES
Publication
Application
Priority
- CA 9900371 W 19990422
- US 8266598 P 19980422
- US 11163598 P 19981209
- US 29566399 A 19990421
Abstract (en)
[origin: WO9954445A2] The present invention relates to methods for increasing the efficiency of transformation of cycling cells, the methods comprising synchronizing cells at a first stage of the cell cycle, and transforming the cells at a second stage of the cell cycle within about one cell cycle of the first stage with a genetically engineered nucleic acid that encodes a desired gene product. The invention further relates to cancer therapy and, in particular, to methods of efficiently transforming cancer cells with nucleic acids that encode gene products that inhibit the growth of cancer cells.
IPC 1-7
IPC 8 full level
A61K 41/00 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/87 (2006.01)
CPC (source: EP)
A61K 41/0038 (2013.01); A61K 48/00 (2013.01); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C12N 15/87 (2013.01)
Citation (search report)
See references of WO 9954445A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9954445 A2 19991028; WO 9954445 A3 19991209; AU 3591299 A 19991108; AU 762986 B2 20030710; CA 2325561 A1 19991028; EP 1082419 A2 20010314; JP 2002512258 A 20020423
DOCDB simple family (application)
CA 9900371 W 19990422; AU 3591299 A 19990422; CA 2325561 A 19990422; EP 99917711 A 19990422; JP 2000544777 A 19990422